NORTH AMERICA SICKLE CELL DISEASE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

North America Sickle Cell Disease Market, By Disease Type (Sickle Cell Anemia, Sickle Beta Thalassemia, Sickle Hemoglobin C Disease), By Drug Type (Hydroxyurea, L-glutamine, Crizanlizumab, Pain-relievers, Voxelotor, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Published In: 25 Mar, 2025
Code: CMI4510
Page number: 166
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Disease Type
  - Market Snippet, By Drug Type
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Country
  - Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- - Market Dynamics
    - Drivers
    - Restraints
    - Market Opportunities
  - Impact Analysis
  - Recent Test Launches
  - Epidemiology
  - Merger, Acquisition, and Collaborations
  - Regulatory Scenario
  - Key Developments
  - PEST Analysis
  - PORTER’S Analysis
  - Pipeline Analysis
North America Sickle Cell Disease Market, By Disease Type, 2021 - 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022-2033
  - Segment Trends
- Sickle Cell Anemia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Segment Trends
- Sickle Beta Thalassemia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Segment Trends
- Sickle Hemoglobin C Disease
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Segment Trends
North America Sickle Cell Disease Market, By Drug Type, 2021 - 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022-2033
  - Segment Trends
- Hydroxyurea
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Segment Trends
- L-glutamine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Segment Trends
- Crizanlizumab
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Segment Trends
- Pain-relievers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Segment Trends
- Voxelotor
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Segment Trends
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Segment Trends
North America Sickle Cell Disease Market, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022-2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
North America Sickle Cell Disease Market, By Country, 2021 - 2033, (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022-2033
  - Segment Trends
- U.S.
  - Introduction
  - Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, Y-o-Y Growth and By Disease Type, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Mn)
- Canada
  - Introduction
  - Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, Y-o-Y Growth and By Disease Type, 2021 - 2033, (US$ Mn)
  - Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Mn)
Competitive Landscape
- Company Profiles
  - Novartis International AG*
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Bristol-Myers Squibb Company
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Global Blood Therapeutics, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Pfizer Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Emmaus Life Sciences, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - ADDMEDICA
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Sangamo Therapeutics, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Acceleron Pharma, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Agios Pharmaceuticals, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Chiesi Farmaceutici S.p.A.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Vertex Pharmaceuticals, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - IMARA, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - CRISPR Therapeutics
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Scribe Therapeutics Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Fulcrum Therapeutics, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - HPC International
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Editas Medicine, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Nicox SA
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Fera Pharmaceuticals
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Tessera Therapeutics
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
Section
- References
- Research Methodology
- About us and Sales Contact

*Browse 17 market data tables and 24 figures on “North America Sickle Cell Disease Market” – North America forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now